Work

Supplemental Figure 2 from A Phase I/Ib Study of Enzalutamide Alone and in Combination with Endocrine Therapies in Women with Advanced Breast Cancer

Year: 2023

Type: supplementary-materials

Abstract: Relationships between aromatase inhibitor plasma exposures (AUCtau) and concentrations of (A, B) estradiol and (C, D) estrone in individual patients. Red lines indicate expected estrogen levels with anastrozole or exemestane use

DOI: 10.1158/1078-0432.22469244.v1

Authors: Lee S. Schwartzberg, Denise A. Yardley, Anthony D. Elias, Manish Patel, Patricia LoRusso, Howard A. Burris, Ayca Gucalp, Amy C. Peterson, Martha E. Blaney, Joyce L. Steinberg, Jacqueline A. Gibbons, Tiffany A. Traina

Language: English

Topic: Advanced Breast Cancer Therapies

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4361967603

Cites:

Cited by:

Related to: 10